Cuál es el precio por Kobayashi Pharmaceutical Co., Ltd. (4967)

Precio por Kobayashi Pharmaceutical Co., Ltd. (4967) es de$37.06

Cuál es la capitalización de mercado por Kobayashi Pharmaceutical Co., Ltd. (4967)

Capitalización de mercado por Kobayashi Pharmaceutical Co., Ltd. (4967) es $2.75B

Ingresos de Kobayashi Pharmaceutical Co., Ltd. (4967)

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Año	Ingresos	Cambiar
Not enough data for the provided dates.

Año

Ingresos

Cambiar

Not enough data for the provided dates.

Empresa	Ingresos	Diferencia de ingresos	País
The Procter & Gamble Company PG.US	$87.03B	-	US
L'Oréal S.A. OR.PA	$51.67B	-	FR
Colgate-Palmolive Company CL.US	$21.05B	-	US
Hindustan Unilever Limited HINDUNILVR.NS	$7.28B	-	IN
The Estée Lauder Companies Inc. EL.US	$15.05B	-	US

Empresa

Ingresos

Diferencia de ingresos

País